chrisvoncsefalvay/vaers-outcomes huggingface dataset:
101 degree F fever. Chills, severe fatigue, body aches. Low appetite. Lasted for 36 hours.
A nurse reported that a 4 month old male received his first injection of Prevnar and subsequently developed a fever and irritability. He recovered in 2 days. No further info was available at the date of this report.
I pulled up 0.3ml from a vial in our Immunization prep area and it had not been diluted. Other pharmacist had pulled out and left vial that was not open. I believed it was an extra dose from the vial she had been administering from.
This spontaneous case was reported by a consumer and describes the occurrence of DIARRHEA (Other patients stated they had diarrhea) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced DIARRHOEA (Other patients stated they had diarrhea). At the time of the report, DIARRHEA (Other patients stated they had diarrhea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported. No treatment details were reported. Event outcome was not reported.
Swelling of some fingers in both hands; Bad body rash; Aches; Joint pain; High fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (Swelling of some fingers in both hands), RASH (Bad body rash), MYALGIA (Aches), ARTHRALGIA (Joint pain) and PYREXIA (High fever) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swelling of some fingers in both hands), RASH (Bad body rash), MYALGIA (Aches), ARTHRALGIA (Joint pain) and PYREXIA (High fever). The patient was treated with CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (Swelling of some fingers in both hands), RASH (Bad body rash) and PYREXIA (High fever) outcome was unknown and MYALGIA (Aches) and ARTHRALGIA (Joint pain) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
nausea, and vomiting on the day of the shot, went away by the next day
Customer returned to the pharmacy with swollen right arm (tricep region). The area was red, warm, and tender to touch. Customer stated this reaction had been ongoing for  2 days.
Information has been received from a registered nurse concerning a 12 month old female who on 28 Aug 2006 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (+) varicella virus vaccine live.  On 28-Aug-2006, after the dose was given, the patient started crying excessively. Unspecified medical attention was sought and the patient recovered.  A product quality complaint was not involved.  Additional information has been requested.
Patient reports red warm area surrounding where vaccine administered.  She feels it may be cellulitis, did not have physician confirmation on this.  No treatment being given at time of report.
PNEUMOVAX 23 given 8/16. 15 hrs post vaccine pt. developed swelling and pain throughout the (L) injection arm. Swelling is spreading throughout the arm w/ pain associated. Have advised pt. to take OTC BENADRYL and monitor and if swelling continues, see PCP.
Experiencing some pain in that arm; The initial case was missing the following minimum criteria: adverse event. Upon receipt of follow-up information on 10Mar2021, this case now contains all required information to be considered valid.  This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection), via an unspecified route of administration on 09Mar2021 (lot number: EM9809) as 1st dose, single dose for COVID-19 immunization. Medical history included diabetes and dental extraction. Concomitant medications included glipizide, metformin, and pioglitazone - all for diabetes. The patient reported that she took BNT162B2 on 09Mar2021 and was experiencing some pain in that arm. The patient mentioned that the doctor told her that she could take some Tylenol, but she doesn't have Tylenol, what she had were some Aleve and Naprosyn - the patient asked if it would affect the vaccine. The patient also asked about concomitant use with dental extraction and diabetic medications metformin, glipizide, and pioglitazone. The outcome of the event was unknown.  Follow-up attempts are completed. No further information is expected.
This spontaneous report as received from a physician assistant refers to a 63 year old male patient with diabetes and neuropathy right leg. On 01-OCT-2013 the patient was vaccinated with ZOSTAVAX. On 07-OCT-2013, seven days after receiving ZOSTAVAX the patient experienced severe pain and a dermatological rash. Patient presented to the medical office on 16-OCT-2013, in which the physician assistant noted the patient had experienced a "burning herpetic pain in a dermatomal distribution radiating from back to front, left side mid thoracic region three inches above the umbilicus'. Physician assistant also reported there were no signs of any vesicular pustules, but possibly a rash "under the skin". Physician assistant also reproted that the patient was quite uncomfortable from pain and had prescribed him an unspecified pain medication. No lab diagnostics studies performed. The outcome of the adverse events was reported as not recovered/not resolved. Additional information has been requested.
Extreme red rash at injection site. Area approximately 4 1/2 inch long, 2 inches wide occurred on the 22nd. Rash became feverish and swollen. Because of previous reaction to injection 1 and doctor's recommendation, I began taking Benadryl on the 21st.   I'm continuing to take Benadryl every day and using an ice pack occasionally.  Reported rash on 1st injection on January 27.
Possible MSG reaction, probably aggravated after vaccination.   Had meal approx. 1 hour before vaccination.   After vaccination (roughly 45 minutes), felt "foggy" feeling, akin to being drunk.   After looking for possible links to vaccine, and given that the reaction seemed like a strong reaction previously attributed to  MSG, searched the ingredients listed by the caterer and found that a side dish listed MSG.   ~~  Drove home without incident.  "Foggy" feeling dissipated after a few hours.   No significant reaction to the vaccine itself except slightly sore arm.
Cough; dizziness; rash all over my body; face is red; Hot and cold flashes; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), DIZZINESS (dizziness), RASH (rash all over my body), ERYTHEMA (face is red) and HOT FLUSH (Hot and cold flashes) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced COUGH (Cough), DIZZINESS (dizziness), RASH (rash all over my body), ERYTHEMA (face is red) and HOT FLUSH (Hot and cold flashes). At the time of the report, COUGH (Cough), DIZZINESS (dizziness), RASH (rash all over my body), ERYTHEMA (face is red) and HOT FLUSH (Hot and cold flashes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not provided.
vasculitis on both arms and legs.  itching and red blotchy areas on all limbs
if she could take a different vaccine (from another manufacturer) for her second dose since she had an allergic reaction to the first dose of the Pfizer vaccine; her bottom lip started swelling; rash; she had an allergic reaction to the first dose of the Pfizer vaccine; This is a spontaneous report from contactable consumer (patient). A 53-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EW0185 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 13May2021 at 16:00 (age at vaccination: 53 years), as dose 1, single dose for COVID-19 immunization. The patient taking Covid Vaccine as she wanted to be protected because she works at a store. The patient's medical history and concomitant medications were not reported. The patient did not have family medical history relevant to adverse events. The patient asked if she could take a different vaccine (from another manufacturer) for her second dose since she had an allergic reaction to the first dose of the Pfizer vaccine On an unspecified date in May2021. The patient reported (with assistance of her daughter as interpreter) that she received her first vaccine dose and afterwards her bottom lip started swelling and she started having a rash on 14May2021. She was told by her HCP that she should not get the second dose for fear her throat would close up. She now asked if it was possible or ok to get the second dose from a different manufacturer to complete the series. The patient received Methylprednisolone 4mg 6 Day Treatment and Fexofenadine 180mg as treatment. The adverse events did not require a visit to emergency room; however, it was resulted in physician office. The patient asked, so since her doctor said she couldn't take the second dose of the Pfizer vaccine, could she take a different vaccine than Pfizer for the second shot. Outcome of the event her bottom lip started swelling and rash was recovered on 15May2021 and for all other events, it was unknown.  Follow-up attempts completed. No further information expected.
fever and chills the following day, then progressive sore throat, cough and hoarseness that has lasted since
Extreme arm pain, body aches, uncontrolled shivering/shaking.  Called physician on call and told to take Benadryl. The next 2 days had low-grade fever. Over next 2 weeks worsening of arm pain and limited movement. Went to orthopedic and diagnosed with bursitis in left shoulder.
Red welt size of palm - approx. 4" x 3" with heat. Said the spot is hard. Noticed on same evening of injection.
This spontaneous report as received from a nurse practitioner refers to incorrect product storage because on an unknown date multiple unspecified patients of unknown ages and genders were vaccinated with an improperly stored doses of GARDASIL (dose, lot #, expiration date and route were not reported). No adverse effects reported. It was unknown if the patients sought medical attention. This is one of several reports from the same source. Additional information has been requested.
body ache for 2 weeks; chills for 2 weeks; muscle pain for 2 weeks; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body ache for 2 weeks), CHILLS (chills for 2 weeks) and MYALGIA (muscle pain for 2 weeks) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN (body ache for 2 weeks), CHILLS (chills for 2 weeks) and MYALGIA (muscle pain for 2 weeks). At the time of the report, PAIN (body ache for 2 weeks), CHILLS (chills for 2 weeks) and MYALGIA (muscle pain for 2 weeks) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant information was reported. Treatment information was not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
she had a mass underneath her left arm; sore muscle sand such; This is a spontaneous report from a contactable reporter (patient). A 59-years-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on 20Apr2021 as dose 2, single in the left arm for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on unspecified date as dose 1, single for covid-19 immunisation. On Apr2021, the patient experienced sore muscle sand such and on 22Apr2021 she had a mass underneath her left arm that was not there two days ago, and states that this is the same arm that she received her injection in. The outcome of the events was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
woke up with chills, slight headache & body acheness lasting 24 hrs. took ibuprofen as needed. left arm where injection was given was really sore the first 24-48 hrs.
Systemic: Fainting / Unresponsive-Mild, Systemic: Weakness-Mild, Additional Details: PATIENT RECIEVED MODERNA BOOSTER IN LEFT DELTOID AND BEGAN TO FEEL FAINT. PT DRANK SOME WATER AND STATED HE WAS READY TO RECIEVE THE FLU SHOT. THE FLU SHOT WAS ADMINISTERED IN THE RIGHT DELTOID AND PATIENT IMMEDIATELY FAINTED. PATIENT REPORTED HISTORY OF FAINTING AFTER RECIEVING VACCINES. PT BECAME CONSCIOUS AND WAS MONITORED FOR 30 MINUTES BEFORE LEAVING THE PHARMACY. PT WAS ABLE TO WALK OUT.
Pt reported difficulty breathing, tightness in her throat and felt very dizzy.  She was noted to be red faced along with redness in her throat and chest.  Pt given Benadryl 25 mg liquid po at 0925 am and coaching for slowed breathing and symptoms recovery.  She reported feeling better gradually and with in 15 minutes pt felt much better she declined ER transport
During morning pill line on 01-15-21, this patient showed me a bruise on the arm where she received her covid shot. The arm was warm in comparison to the other arm, and was visibly raised. She mentioned that the warmth she felt was bothersome.I checked her arm again Saturday morning, and it was again raised, and warm.    On 01-17-21, the bulging raise on her arm is still there, but she has not experienced any uncomfortable warm feeling.   This resolved on 01-19-21. Patient was seen by provider who examined her and prescribed ibuprofen 600mg
had an allergic reaction (tongue swelling and throat closing) after taking the vaccine; This is a spontaneous report from a contactable consumer. The consumer reported similar events for 2 patients. This is 1st of two reports.  An elderly female patient of an unspecified age received the BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported) via an unspecified route of administration on 22Jan2021 as a single dose for Covid-19 immunization in Hospital. Medical history and concomitant medications were not reported. It was unknown whether patient had COVID prior vaccination or post vaccination. On 22Jan2021, the patient experienced allergic reaction (tongue swelling and throat closing) after taking the vaccine, which resulted in emergency room/department or urgent care. Patient self administered Epi-pens as treatment for the event. The adverse reaction was reversed by the single use of the individual epipens. The outcome of the event was recovered.  Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : PFIZER INC-2021088128 same reporter/ drug, different patient/ similar AE
Rectal bleeding; Colitis attack; Diarrhea; Sweats; Vomiting; A spontaneous report  was received from a consumer concerning a 72-year-old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced  colitis attack/colitis, diarrhea/diarrhoea, vomiting, rectal bleeding/rectal hemorrhage and sweats/hyperhidrosis.  The patient's medical history was not provided. Concomitant medications list was also not provided.  On 11 Feb 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (batch number: 030MZ0A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.  On 11 Mar 2021, prior to the onset of the events, the patient received their second dose of two planned doses of mRNA-1273 (batch number: 032M20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.   On 11 Mar 2021, after receiving the second dose of mRNA-1273, the patient had a terrible gastrointestinal situation. She had an emergency CAT (computerized axial tomography) scan from her gastro doctor which brought on a colitis attack which she normally does not have. She experienced diarrhea, vomiting, sweats and rectal bleeding.   The patient received both scheduled doses of mRNA-1273 prior to the event(s); therefore, action taken with the drug in response to the event(s) is not applicable.  The outcome of the events,  colitis attack, diarrhea, vomiting, rectal bleeding and sweats, were considered to be unknown at the time of this report.; Reporter's Comments: Very limited information regarding this event/s has been provided at this time.  Further information cannot be obtained since the patient has declined.
Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021; Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.   No Medical History information was reported.  On 15-Apr-2021 at 1:46 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 15-Apr-2021 at 1:46 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021) outcome was unknown. Not Provided    For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 41.40  No concomitant medications were reported.  Batch number 044B21A underwent temperature excursion on 15-Apr-2021 with temperature 34 degrees Fahrenheit from 9 AM. 18 vials were moved to fridge on 06-Apr-2021 and beyond use date for the vial was reported as 09-May-2021. Product moved to clinic on 15-Apr-2021.  Vial was stored in cooler 1, on 15-Apr-2021, temperature excursion at 9 AM: 34, 10 AM: 36, 11 AM: 38, 12 PM: 39, 1PM: 43, 2 PM: 44 and 3 PM: 44.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  The healthcare professional (HCP) reported that, each time a vial was put into a cooler, sometimes there was a period of time of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. The vial was stored in cooler storage during high-pace COVID-19 vaccination clinic at the time of excursion. Temperature recordings were taken using a Fisherbrand traceable temperature monitor at every hour.  The vial was not in a frozen state at the time of vaccine administration.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  No treatment information was provided.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Additional Details: Patient was sitting in chair and rested head on arms. Then he fell out of chair onto floor. Immediately woke up after rph-on-duty went to him. He sat on floor for approximately 3 minutes and then was feeling well enough to sit in chair. Patient was able to communicate and sit in chair again. Patient stayed at pharmacy for approximately 30 minutes and was well enough to walk on own. No other issues reported by patient.
About a week after receiving my third dose, I started to notice that I had a continuous mild cough, but it started to get worse. I was treated for a sinus infection and given antibiotics. When the doctor listened to my lungs, they were fairly clear, but she felt that I should take a round of antibiotics.
High fever, body aches, sore throat, runny nose, sore arm from injection (red and swollen).
She was spotting for months on end; This spontaneous case was reported by a consumer and describes the occurrence of INTERMENSTRUAL BLEEDING (She was spotting for months on end) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INTERMENSTRUAL BLEEDING (She was spotting for months on end). At the time of the report, INTERMENSTRUAL BLEEDING (She was spotting for months on end) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided.  No treatment medication was provided.   This case was linked to MOD-2022-471336 (Patient Link).
Fully vaccinated, not eligible for booster yet.   Asymptomatic COVID + in prep for planned full term C section (39 w gestation) Baby born. Baby Wt  no documented yet   Apgar  9/9.   All stable.
Site: Itching at Injection Site-Severe, Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Allergic: Itch Generalized-Severe, Systemic: Chest Tightness / Heaviness / Pain-Mild
1/4/2020 vaccine few hours later, started to experience dizzy, SOB. I passed out on the floor, still conscious. Felt weak, sat up. Sweating profusely. Migraine. I went home from work. Couldn't move arm; extreme soreness. Body aches, chills, fever at nights. Peaked within 24 hours. 2-3 days, 2nd day being the hardest.  Within couple days, I felt fine.